Skip to main content

Bladder Outlet Obstruction

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
1 program
1
ToviazPhase 41 trial
Active Trials
NCT00605319Completed17Est. Jan 2013
ConvaTec
ConvaTecNJ - Bridgewater
1 program
Intermittent self-catheterisationN/A1 trial
Active Trials
NCT05470751Completed72Est. Apr 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PfizerToviaz
ConvaTecIntermittent self-catheterisation

Clinical Trials (2)

Total enrollment: 89 patients across 2 trials

An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for Benign Prostatic Hyperplasia

Start: Jan 2010Est. completion: Jan 201317 patients
Phase 4Completed
NCT05470751ConvaTecIntermittent self-catheterisation

GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology

Start: Feb 2023Est. completion: Apr 202472 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.